Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing

New Delhi metallo-β-lactamases bacteremia carbapenem-resistant

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 05 11 2019
accepted: 08 01 2020
entrez: 12 2 2020
pubmed: 12 2 2020
medline: 12 2 2020
Statut: epublish

Résumé

Limited data about New Delhi metallo-β-lactamase (NDM) bacteremia are available. Blood isolates from 40 patients with NDM bacteremia were studied for antibiotic susceptibility and whole-genomic sequencing. NDM bacteremia has high 30-day mortality. In most cases, aztreonam-avibactam is active in vitro. Ceftazidime-avibactam plus aztreonam may represent a feasible therapeutic option.

Identifiants

pubmed: 32042848
doi: 10.1093/ofid/ofaa011
pii: ofaa011
pmc: PMC7003035
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofaa011

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

J Antimicrob Chemother. 2011 Nov;66(11):2677-8
pubmed: 21846669
Am J Case Rep. 2017 Jul 18;18:805-809
pubmed: 28717120
Epidemiol Infect. 2019 Jan;147:e137
pubmed: 30869056
Clin Infect Dis. 2019 Dec 05;:
pubmed: 31802119
Clin Microbiol Infect. 2016 May;22(5):444-50
pubmed: 26850826
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630191
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Future Microbiol. 2017 Oct;12:1119-1122
pubmed: 28876082
Diagn Microbiol Infect Dis. 2016 Sep;86(1):30-4
pubmed: 27345126
Clin Microbiol Rev. 2019 Jan 30;32(2):
pubmed: 30700432
J Antimicrob Chemother. 2016 Oct;71(10):2713-22
pubmed: 27432599
J Antimicrob Chemother. 2018 Apr 1;73(4):1104-1106
pubmed: 29272413
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28167541
Scand J Infect Dis. 2012 Apr;44(4):312-4
pubmed: 22126430
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338

Auteurs

Marco Falcone (M)

Infectious Disease Unit, Azienda Ospedaliera Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Giusy Tiseo (G)

Infectious Disease Unit, Azienda Ospedaliera Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Alberto Antonelli (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Cesira Giordano (C)

Microbiology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Vincenzo Di Pilato (V)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Pietro Bertolucci (P)

Faculty of Medicine, University of Pisa, Pisa, Italy.

Eva Maria Parisio (EM)

Operative Unit of Chemical-Clinical and Microbiological Analysis, San Luca Hospital, Lucca, Italy.

Alessandro Leonildi (A)

Faculty of Medicine, University of Pisa, Pisa, Italy.

Noemi Aiezza (N)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Ilaria Baccani (I)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Enrico Tagliaferri (E)

Infectious Diseases Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Lorenzo Righi (L)

Quality of Care and Clinical Networks, Tuscany Region, Italy.

Silvia Forni (S)

Agenzia Regionale di Sanità della Toscana, Florence, Italy.

Spartaco Sani (S)

Infectious Disease Unit, Livorno Hospital, Livorno, Italy.

Maria Teresa Mechi (MT)

Quality of Care and Clinical Networks, Tuscany Region, Italy.

Filippo Pieralli (F)

Intermediate Care Unit, Florence Careggi University Hospital, Florence, Italy.

Simona Barnini (S)

Microbiology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Gian Maria Rossolini (GM)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.

Francesco Menichetti (F)

Infectious Disease Unit, Azienda Ospedaliera Universitaria Pisana, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Classifications MeSH